Follow the ASTRO MED INC /NEW/ stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.7m. The latest transaction was disclosed on 10 February 2016 (Attribution). Among the most active insiders: Natalizia Michael J. The full history is openly available.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 19,065 of 29,055 companies
41.7
score / 100
Value
50
Quality
34
FCF yld·
Earn yld-118%
EV/EBITDA2.3x
ROE·
Gross mgn32%
Net mgn-1.6%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ASTRO MED INC /NEW/ is a company listed on the XNAS market, specializing in the development of medical technologies. It focuses on providing innovative solutions for the healthcare sector.